Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-03-18
2008-03-18
Solola, Taofiq (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S252000
Reexamination Certificate
active
10913121
ABSTRACT:
Improved processes using primary, secondary and tertiary alcohols and with safer mode of introduction of the reagent and reaction conditions are described. Further, the process of manufacture of Losartan potassium by use of alkali metal salt such as Potassium carbonate is disclosed. A process for preparation of the polymorphic Form I of Losartan potassium is also disclosed herein.
REFERENCES:
patent: 5138069 (1992-08-01), Carini et al.
patent: 5281603 (1994-01-01), Venkatesan et al.
patent: 5281604 (1994-01-01), Levin et al.
patent: 5608075 (1997-03-01), Campbell, Jr. et al.
patent: WO 93/10106 (1993-05-01), None
patent: WO 95/17396 (1995-06-01), None
patent: WO 98/18787 (1998-05-01), None
patent: WO 01/81336 (2001-11-01), None
patent: WO 02/094816 (2002-11-01), None
patent: WO 03/048135 (2003-06-01), None
patent: WO 03/093262 (2003-11-01), None
Burrell, Drug Safety, (1997), vol. 16(1), pp. 56-65.
Kumar Ashok
Nimbalkar Manmohan Madhavrao
Panda Nalinakshya Balaram
Saxena Ashvini Kumar Nand Kishore
Singh Rajesh Kumar Keshava Prasad
Blank Rome LLP
IPCA Laboratories Limited
Solola Taofiq
LandOfFree
Process for the synthesis of Losartan potassium does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for the synthesis of Losartan potassium, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the synthesis of Losartan potassium will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3909002